No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
China Traditional Chinese Medicine Holdings Co. Limited functions as an investment holding company, primarily focusing on the research, development, and sale of traditional Chinese medicine and other pharmaceutical goods across the People's Republic of China. The company's product range includes medicinal granules, finished pharmaceutical preparations, pre-portioned decoction materials, and various healthcare products. Furthermore, its operations extend to the cultivation and management of Chinese medicinal herbs, the manufacturing of traditional Chinese medicines, and the trading of pharmaceutical products. It also delivers marketing, advertising, and consulting services related to TCM, and operates retail outlets for pharmaceuticals and decoction products. Property leasing services represent another facet of its business. The company distributes its products to healthcare facilities and retail pharmacies. Established in 1573 and headquartered in Wan Chai, Hong Kong, the firm was formerly known as China Traditional Chinese Medicine Co. Limited before adopting its current name in July 2016.
www.china-tcm.com.cnNo one on the platform currently holds 0570.HK.
No tracked institution reports a position in 0570.HK as of their last filing.
No one on the platform has traded 0570.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | -10.7% | -0.1% | ||||
| Profit Margin % | -2.3% | 4.1% | 8.5% | |||
| Free Cash Flow Margin % | 13.3% | 6.6% | 5.5% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $15.2B | -2.9% | $-0.09 | $-0.13–$-0.06 | — | 2 |
| 2027 | $15.7B | +3.6% | $0.09 | $0.09–$0.10 | — | 2 |
| 2028 | $17.9B | +13.9% | $0.17 | $0.16–$0.17 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 0570.HKChina Traditional Chinese Medicine Holdings Co. Limited | $1.27 | +1.19% | $6.4B | — |
| 0460.HKSihuan Pharmaceutical Holdings Group Ltd. | $0.71 | -3.40% | $6.4B | — |
| 0719.HKShandong Xinhua Pharmaceutical Company Limited | $5.42 | -1.36% | $8.2B | — |
| 1681.HKConsun Pharmaceutical Group Limited | $13.26 | -0.15% | $11.1B | — |
| 2005.HKSSY Group Limited |
| $2.70 |
| +2.08% |
| $7.8B |
| — |
| 2157.HKLepu Biopharma Co., Ltd. | $3.98 | +0.00% | $7.2B | — |
| 2186.HKLuye Pharma Group Ltd. | $1.79 | +0.28% | $7.2B | — |
Source: Financial Modeling Prep · peers by sector/industry